Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer

Lung cancer is the common malignant tumor with the highest mortality rate. Lung cancer patients have achieved benefits from immunotherapy, including immune checkpoint inhibitors (ICIs) therapy. Unfortunately, cancer patients acquire adaptive immune resistance, leading to poor prognosis. Tumor microe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Man, Zhu, Lijie, Yang, Xiaoxu, Li, Jiahui, Liu, Yu’e, Tang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974851/
https://www.ncbi.nlm.nih.gov/pubmed/36874015
http://dx.doi.org/10.3389/fphar.2023.1132158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974851/
https://www.ncbi.nlm.nih.gov/pubmed/36874015
http://dx.doi.org/10.3389/fphar.2023.1132158

Ejemplares similares